Safety and Efficacy of Emicizumab in Persons with Hemophilia a with or without FVIII Inhibitors: Pooled Data from Four Phase III Studies (HAVEN 1-4)
Year: 2020
Type: article
Source: Blood
Authors: Michael U. Callaghan, Claude Négrier, Ido Paz-Priel, Tiffany Chang, Sammy Chebon, Michaela Lehle, Johnny Mahlangu, Guy Young, Rebecca Kruse-Jarres, Maria Elisa Mancuso, Markus Niggli, Peter Kuebler, Nives Selak Bienz, Midori Shima, Victor Jimenez-Yuste, Christophe Schmitt, Elina Asikanius, Gallia Levy, Steven W. Pipe, Johannes Oldenburg
Institutions: Children's Hospital of Michigan, Hôpital Edouard Herriot, Genentech, F. Hoffmann-La Roche AG, University of the Witwatersrand, University of Southern California, Children's Hospital Los Angeles, Bloodworks Northwest, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Nara Medical University Hospital, Hospital Universitario La Paz, University of Michigan, University of Bonn
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3097598574